T. Rowe Price Investment Management
BLFS icon

T. Rowe Price Investment Management’s BioLife Solutions BLFS Stock Holding History

T. Rowe Price Investment Management’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$124M Buy
6,506,346
+1,325,522
+26% +$29.3M 0.09% 223
2025
Q4 		$125M Buy
5,180,824
+1,113,972
+27% +$29.1M 0.08% 225
2025
Q3 		$104M Sell
4,066,852
-179,854
-4% -$4.27M 0.06% 264
2025
Q2 		$91.5M Buy
4,246,706
+2,898,698
+215% +$65.3M 0.06% 290
2025
Q1 		$30.8M Buy
+1,348,008
New +$35.5M 0.02% 469

Other funds holding BLFS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

T. Rowe Price Investment Management's BLFS Position: Q1 2026 in Review

T. Rowe Price Investment Management increased its BioLife Solutions (BLFS) stake by 26% in Q1 2026, buying an estimated $29.3M and bringing the position to 6,506,346 shares worth $124M. The position accounts for 0.09% of the portfolio, ranked #223.

T. Rowe Price Investment Management first reported a position in BLFS in Q1 2025 and has held it in 5 quarters since. The position peaked at $125M in Q4 2025. 187 funds tracked by Wall St. Rank hold BLFS as of Q1 2026.

  • T. Rowe Price Investment Management held 6,506,346 shares of BioLife Solutions worth $124M as of Q1 2026.
  • T. Rowe Price Investment Management bought 1,325,522 BioLife Solutions shares in Q1 2026, an estimated $29.3M.
  • BioLife Solutions made up 0.09% of T. Rowe Price Investment Management's portfolio in Q1 2026, its #223 holding.
  • T. Rowe Price Investment Management first reported a position in BioLife Solutions in Q1 2025 and has held it in 5 quarters since.
  • T. Rowe Price Investment Management's BioLife Solutions position peaked at $125M in Q4 2025.
  • 187 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2026.

Based on T. Rowe Price Investment Management's 13F filing for Q1 2026, filed 15 May 2026.